Source: Eur Respir J, 50 (6) 1702023; 10.1183/13993003.02023-2017
Disease area: Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
Miriam E. Abadie, Jeffrey R. Strich, Tiffany Kim, Yingda L. Xie, Kevin P. Fennelly, Kenneth N. Olivier, Meryl Waldman, Kriti Arora, Steven M. Holland, Ray Y. Chen. Renal Fanconi syndrome with meropenem/amoxicillin-clavulanate during treatment of extensively drug-resistant tuberculosis. Eur Respir J, 50 (6) 1702023; 10.1183/13993003.02023-2017

Member's Comments

No comment yet.

Related content which might interest you: Renal Fanconi syndrome with meropenem-containing regimen in drug-resistant tuberculosis Source: Eur Respir J, 51 (3) 1702187; 10.1183/13993003.02187-2017 Year: 2018 Nephrotic syndrome associated with pulmonary tuberculosis – case presentation Source: Eur Respir J 2007; 30: Suppl. 51, 88s Year: 2007 Treatment options for patients with multidrug-resistant or extensively drug-resistant tuberculosis Source: Annual Congress 2009 - Priorities in tuberculosis research Year: 2009 Fever syndrome in AIDS and tuberculosis patient Source: Eur Respir J 2006; 28: Suppl. 50, 128s Year: 2006 Risk factors for treatment failure in multidrug-resistant and extensively drug-resistant tuberculosis in Estonia Source: Annual Congress 2008 - Epidemiological and clinical aspects of tuberculosis control Year: 2008 Acute renal failure due to rifampicin during tuberculosis treatment Source: Annual Congress 2007 - Medical and surgical treatment of susceptible and resistant tuberculosis Year: 2007 Paradoxical reactions in non-HIV tuberculosis presenting as endobronchial obstruction Source: Eur Respir Rev 2009; 18: 295-299 Year: 2009 Nontuberculous mycobacterial pneumonia associated with the triple A syndrome Source: Eur Respir J 2005; 26: Suppl. 49, 624s Year: 2005 Management and treatment of multidrug-resistant tuberculosis Source: International Congress 2019 – Tuberculosis: latest advances and challenges in patient management Year: 2019 Renal failure as first manifestation of familial sarcoidosis Source: Eur Respir J 2010; 36: 1485-1487 Year: 2010 Clinical outcomes of patients with drug-resistant and extensively drug-resistant tuberculosis in Europe Source: Annual Congress 2008 - Priorities for tuberculosis research in Europe: discussing the results of the Tuberculosis Network European Trials Group (TBNET) Year: 2008 Early pulmonary phenotype in Hermansky-Pudlak syndrome: Analysis of the chILD-EU registry Source: International Congress 2016 – Paediatric bronchology I Year: 2016 A case of resistance beyond extensively drug-resistant tuberculosis in Japan Source: Eur Respir J 2013; 42: 870-872 Year: 2013 A case of resistance beyond extensively drug-resistant tuberculosis in Japan Source: Eur Respir J 2013; 42: 872-873 Year: 2013 Extrapulmonary tuberculosis in patients with chronic kidney disease receiving renal replacement therapy Source: International Congress 2019 – Tuberculosis and comorbidities Year: 2019 Specific features of acute renal failure in rifampicin treated patients for pulmonary tuberculosis Source: Eur Respir J 2002; 20: Suppl. 38, 609s Year: 2002 Hepatopulmonary syndrome in non-cirrhotic patients with chronic viral hepatitis Source: International Congress 2015 – Pulmonary hypertension in lung disease Year: 2015 Bedaquiline in the treatment of multidrug- and extensively drug-resistant tuberculosis Source: Eur Respir J 2016; 47: 564-574 Year: 2016 Diabetes is associated with genotypically drug-resistant tuberculosis Source: Eur Respir J, 55 (3) 1901891; 10.1183/13993003.01891-2019 Year: 2020